Preferred Label : oxybutynin;
MeSH note : RN given refers to parent cpd;
CISMeF synonym : 1508-65-2 (HCl); 1508-65-2 (oxybutynin hydrochloride); AbZ brand of oxybutynin hydrochloride; Apo-Oxybutynin; CCD brand of oxybutynin hydrochloride; Gen-Oxybutynin; Novo-Oxybutynin; Nu-Oxybutyn; Nu-Pharm brand of oxybutynin hydrochloride; Oxybutynin-Puren; PMS-Oxybutynin; TAD brand of oxybutynin hydrochloride; abbott brand of oxybutynin hydrochloride; aliud brand of oxybutynin hydrochloride; allphar brand of oxybutynin hydrochloride; alpharma brand of oxybutynin hydrochloride; apotex brand of oxybutynin hydrochloride; asofarma brand of oxybutynin hydrochloride; aventis brand of oxybutynin hydrochloride; azupharma brand of oxybutynin hydrochloride; berk brand of oxybutynin hydrochloride; byk brand of oxybutynin hydrochloride; clonmel brand of oxybutynin hydrochloride; contimin; ct-Arzneimittel brand of oxybutynin hydrochloride; cystonorm; ditropan; dresplan; driptane; esparma brand of oxybutynin hydrochloride; fournier brand of oxybutynin hydrochloride; gelnique; genpharm brand of oxybutynin hydrochloride; heumann brand of oxybutynin hydrochloride; hoyer brand of oxybutynin hydrochloride; janssen brand of oxybutynin hydrochloride; kade brand of oxybutynin hydrochloride; novopharm brand of oxybutynin hydrochloride; ortho brand of oxybutynin hydrochloride; oxyb AbZ; oxybugamma; oxybutin holsten; oxybuton; oxybutynin AL; oxybutynin AZU; oxybutynin heumann; oxybutynin hexal; oxybutynin stada; oxybutynin von ct; oxybutynin-ratiopharm; oxymedin; oxytrol; pfleger brand of oxybutynin hydrochloride; pharmascience brand of oxybutynin hydrochloride; pollakisu; ratiopharm brand of oxybutynin hydrochloride; renamel; ryol; sanofi synthelabo brand of oxybutynin hydrochloride; seid brand of oxybutynin hydrochloride; spasmex oxybutynin; spasyt; stadapharm brand of oxybutynin hydrochloride; tavor; wörwag brand of oxybutynin hydrochloride; zatur;
MeSH synonym : 4-(diethylamino)-2-butynyl-alpha-phenylcyclohexaneglycolate; 4-(diethylamino)-2-butynyl-alpha-cyclohexyl-alpha-hydroxybenzeneacetate;
MeSH hyponym : Dridase; Cystrin; oxybutynin chloride;
MeSH Related Number : oxybutynin hydrochloride; 5633-20-5 (oxybutynin); L9F3D9RENQ;
Registry Number MeSH : 5633-20-5;
Related CAS MeSH : L9F3D9RENQ (oxybutynin hydrochloride);
related registry number list (CISMeF) : 1508-65-2 (HCl);
CISMeF hyponym : chlorhydrate d'oxybutynine; oxybutynine chlorhydrate;
Is substance : O;
UNII : K9P6MC7092;
InChIKey : XIQVNETUBQGFHX-UHFFFAOYSA-N;
Origin ID : C005419;
UMLS CUI : C0069805;
ATC code(s)
ATC code(s)
Currated CISMeF NLP mapping
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
https://www.has-sante.fr/portail/jcms/c_2967169/fr/ditropan
2019
true
France
French
Urinary Frequency
urination disorders
urinary incontinence
urinary incontinence, urge
mandelic acids
muscarinic antagonists
oxybutynin
administration, oral
oxybutynin
parasympatholytics
insurance, health, reimbursement
evaluation of the transparency committee
treatment outcome
adult
---
https://www.has-sante.fr/portail/jcms/c_2964635/fr/ditropan
2019
false
false
false
France
oxybutynin hydrochloride
nocturnal enuresis
child
administration, oral
treatment outcome
urological agents
overactive detrusor
oxybutynin
insurance, health, reimbursement
muscarinic antagonists
parasympatholytics
evaluation of the transparency committee
oxybutynin
urinary bladder, overactive
mandelic acids
---
https://minerva-ebp.be/FR/Article/2066
2016
false
false
false
false
Belgium
French
critical appraisal or critical reading
oxybutynin
antiperspirants
treatment outcome
hyperhidrosis
oxybutynin
---
http://www.has-sante.fr/portail/jcms/c_763717/ditropan
http://www.has-sante.fr/portail/jcms/c_1622368/fr/ditropan
http://www.has-sante.fr/portail/jcms/c_1623010/fr/ditropan-26062013-avis-ct12763
2013
France
French
urination disorders
urinary incontinence
urinary incontinence, urge
mandelic acids
muscarinic antagonists
oxybutynin
administration, oral
oxybutynin
parasympatholytics
insurance, health, reimbursement
evaluation of the transparency committee
treatment outcome
adult
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64716418
2012
France
summary of product characteristics
package leaflet
tablets
oxybutynin
---
https://www.ema.europa.eu/medicines/human/EPAR/kentera-previously-oxybutynin-nicobrand
2012
false
United Kingdom
English
French
syndication feed
oxybutynin
oxybutynin
mandelic acids
muscarinic antagonists
muscarinic antagonists
urinary incontinence, urge
mandelic acids
treatment outcome
drug evaluation
drug approval
drug labeling
administration, cutaneous
adult
urinary bladder, overactive
drug interactions
pregnancy
breast feeding
parasympatholytics
parasympatholytics
drug evaluation, preclinical
oxybutynin
mandelic acids
drug evaluation
summary of product characteristics
package leaflet
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61716904
2012
France
summary of product characteristics
package leaflet
tablets
oxybutynin
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63309558
2012
France
summary of product characteristics
package leaflet
tablets
oxybutynin
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64280159
2012
France
summary of product characteristics
package leaflet
tablets
oxybutynin
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60620486
2012
France
summary of product characteristics
package leaflet
tablets
oxybutynin
---
http://www.aboutkidshealth.ca/en/healthaz/drugs/pages/oxybutynin.aspx?k=oxybutynine;+antispasmodique
http://www.aboutkidshealth.ca/Fr/HealthAZ/Drugs/Pages/Oxybutynin.aspx
2010
Canada
French
English
oxybutynin
child
oxybutynin
mandelic acids
mandelic acids
oxybutynin
parasympatholytics
parasympatholytics
urinary incontinence
administration, oral
mandelic acids
drug information
patient education handout
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67037066
2010
France
French
administration, oral
tablets
oxybutynin
oxybutynin
urinary incontinence
parasympatholytics
parasympatholytics
oxybutynin
mandelic acids
mandelic acids
drug interactions
pregnancy
muscarinic antagonists
muscarinic antagonists
urinary incontinence, urge
mandelic acids
summary of product characteristics
package leaflet
---
https://www.cadth.ca/sites/default/files/pdf/184_oxybutynin_cetap_f.pdf
https://www.cadth.ca/sites/default/files/pdf/184_oxybutynin_cetap_e.pdf
2001
Canada
French
English
oxybutynin
oxybutynin
muscarinic antagonists
mandelic acids
administration, cutaneous
canada
treatment outcome
Evidence-Based medicine
urinary bladder, overactive
mandelic acids
clinical trials as topic
oxybutynin
mandelic acids
drug evaluation
health technology assessment
---